Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6439)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2013 (publication date) through Feb 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | García-Samaniego J, Romero M, Granados R, Alemán R, Jorge Juan M, Suárez D, Pérez R, Castellano G, González-Portela C. Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C. World J Gastroenterol 2013; 19(12): 1943-1952 [PMID: 23569340 DOI: 10.3748/wjg.v19.i12.1943] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i12/1943.htm |
| Number | Citing Articles |
| 1 |
Wan‐Long Chuang, Rong‐Nan Chien, Cheng‐Yuan Peng, Ting‐Tsung Chang, Gin‐Ho Lo, I‐Shyan Sheen, Horng‐Yuan Wang, Jyh‐Jou Chen, Jenny C. Yang, Steven J. Knox, Bing Gao, Kimberly L. Garrison, Hongmei Mo, Phillip S. Pang, Yu‐Chun Hsu, Tsung‐Hui Hu, Chi‐Jen Chu, Jia‐Horng Kao. Ledipasvir/sofosbuvir fixed‐dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus. Journal of Gastroenterology and Hepatology 2016; 31(7): 1323 doi: 10.1111/jgh.13305
|
| 2 |
Elena Gentilcore. Long-term outcomes after hepatitis C virus eradication: a message for clinicians. Minerva Medica 2020; 110(6) doi: 10.23736/S0026-4806.19.06211-6
|
| 3 |
S. H. Ahn, Y. S. Lim, K. S. Lee, S. W. Paik, Y. J. Lee, S. H. Jeong, J. H. Kim, S. K. Yoon, H. J. Yim, W. Y. Tak, S. Y. Han, J. C. Yang, H. Mo, A. Mathias, L. Han, S. J. Knox, D. M. Brainard, Y. J. Kim, K. S. Byun, Y. S. Kim, J. Heo, K. H. Han. A phase 3b study of sofosbuvir plus ribavirin in treatment‐naive and treatment‐experienced Korean patients chronically infected with genotype 2 hepatitis C virus. Journal of Viral Hepatitis 2016; 23(5): 358 doi: 10.1111/jvh.12499
|
| 4 |
Jia‐Horng Kao, Rong‐Nan Chien, Ting‐Tsung Chang, Cheng‐Yuan Peng, Tsung‐Hui Hu, Gin‐Ho Lo, Horng‐Yuan Wang, Jyh‐Jou Chen, Jenny C. Yang, Steven J. Knox, Lingling Han, Hongmei Mo, Anita Mathias, Diana M. Brainard, I‐Shyan Sheen, Yu‐Chun Hsu, Chi‐Jen Chu, Wan‐Long Chuang. A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection. Liver International 2016; 36(8): 1101 doi: 10.1111/liv.13082
|
| 5 |
Chiara Rosso, Maria Lorena Abate, Alessia Ciancio, Silvia Strona, Gian Paolo Caviglia, Antonella Olivero, Giovanni Antonio Touscoz, Mario Rizzetto, Rinaldo Pellicano, Antonina Smedile. <italic>IL28B</italic> polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients. World Journal of Gastroenterology 2014; 20(36): 13146-13152 doi: 10.3748/wjg.v20.i36.13146
|
| 6 |
Young-Suk Lim, Sang Hoon Ahn, Kwan Sik Lee, Seung Woon Paik, Youn-Jae Lee, Sook-Hyang Jeong, Ju-Hyun Kim, Seung Kew Yoon, Hyung Joon Yim, Won Young Tak, Sang-Young Han, Jenny C. Yang, Hongmei Mo, Kimberly L. Garrison, Bing Gao, Steven J. Knox, Phillip S. Pang, Yoon Jun Kim, Kwan-Soo Byun, Young Seok Kim, Jeong Heo, Kwang-Hyub Han. A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus. Hepatology International 2016; 10(6): 947 doi: 10.1007/s12072-016-9726-5
|
| 7 |
Young Min Kim, Suk Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae, Myeong Jun Song, Ji Woong Jang, Soon Young Ko, Jae Dong Lee. Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study. Clinical and Molecular Hepatology 2018; 24(3): 311 doi: 10.3350/cmh.2017.0070
|